Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Dormont

Showing results (381-390 of 415) with videos related to

Pageof 42
Sort By:
Arthritis and Rheumatism|April 1, 2009
Cerebral venous thrombosis in Behçet's diseaseD Saadoun, B Wechsler, M Resche-Rigon, et al.
The Journal of Biological Chemistry|March 30, 2001
The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1C Gabus, E Derrington, P Leblanc, et al.
Journal of Neurosurgery|April 13, 2000
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidanceB P Bejjani, D Dormont, B Pidoux, et al.
Neurobiology of Disease|December 15, 2000
Neurotoxicity of the putative transmembrane domain of the prion proteinS Haïk, J M Peyrin, L Lins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 25, 1998
Deep brain stimulation in Parkinson's disease: opposite effects of stimulation in the pallidumB P Bejjani, P Damier, I Arnulf, et al.
AJNR. American Journal of Neuroradiology|September 25, 2020
Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous <sup>18</sup>F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer?N Pyatigorskaya, R De Laroche, G Bera, et al.
Neuropathology and Applied Neurobiology|October 9, 2002
Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaquesF Chrétien, A-V Vallat-Decouvelaere, C Bossuet, et al.
Science (New York, N.Y.)|January 17, 1997
Transmission of the BSE agent to mice in the absence of detectable abnormal prion proteinC I Lasmézas, J P Deslys, O Robain, et al.
The EMBO Journal|November 2, 2001
The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion proteinS Gauczynski, J M Peyrin, S Haïk, et al.
AJNR. American Journal of Neuroradiology|June 1, 1997
Chronic thalamic stimulation with three-dimensional MR stereotactic guidanceD Dormont, P Cornu, B Pidoux, et al.
Pageof 42

Showing results (381-390 of 415) with videos related to

Sort By:
Pageof 42
Arthritis and Rheumatism|April 1, 2009
Cerebral venous thrombosis in Behçet's diseaseD Saadoun, B Wechsler, M Resche-Rigon, et al.
The Journal of Biological Chemistry|March 30, 2001
The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1C Gabus, E Derrington, P Leblanc, et al.
Journal of Neurosurgery|April 13, 2000
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidanceB P Bejjani, D Dormont, B Pidoux, et al.
Neurobiology of Disease|December 15, 2000
Neurotoxicity of the putative transmembrane domain of the prion proteinS Haïk, J M Peyrin, L Lins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 25, 1998
Deep brain stimulation in Parkinson's disease: opposite effects of stimulation in the pallidumB P Bejjani, P Damier, I Arnulf, et al.
AJNR. American Journal of Neuroradiology|September 25, 2020
Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous <sup>18</sup>F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer?N Pyatigorskaya, R De Laroche, G Bera, et al.
Neuropathology and Applied Neurobiology|October 9, 2002
Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaquesF Chrétien, A-V Vallat-Decouvelaere, C Bossuet, et al.
Science (New York, N.Y.)|January 17, 1997
Transmission of the BSE agent to mice in the absence of detectable abnormal prion proteinC I Lasmézas, J P Deslys, O Robain, et al.
The EMBO Journal|November 2, 2001
The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion proteinS Gauczynski, J M Peyrin, S Haïk, et al.
AJNR. American Journal of Neuroradiology|June 1, 1997
Chronic thalamic stimulation with three-dimensional MR stereotactic guidanceD Dormont, P Cornu, B Pidoux, et al.
Pageof 42